Recruiting

HPV Vaccine

Sponsor:

UCLA

Code:

NCT06831929

Conditions

HPV Vaccine

Eligibility Criteria

Sex: All

Age: 10 - 12

Healthy Volunteers: Accepted

Interventions

Intervention Arm

Study Details

Brief summary:

Develop, implement, and evaluate a culturally tailored multilevel intervention to increase uptake of the HPV vaccine among eligible patients ages 10-12 of the University of California, Davis Health Community Physician (UCDH CP) primary care practices using a randomized controlled trial design.

Conditions

HPV Vaccine

Study ID

NCT06831929

Start date

Feb 28, 2025

Status verified date

Aug, 2026

Completion date

Dec 31, 2026

Anticipated

Primary completion date

Feb 5, 2026

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 10 - 12

Healthy Volunteers: Accepted

Inclusion Criteria:

• Clinic patients between the ages of 10-12 who are eligible for the HPV vaccine

Exclusion Criteria:

• Clinic patients who already received the HPV vaccine or with any contraindication to the HPV vaccine.

Study Design

Enrollment

2232 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Prevention

Interventions and Outcome Measures

Arms

no intervention: Control Arm

These clinics will not receive any intervention and will continue with care as usual.

experimental: Intervention Arm

These clinics will receive the multilevel intervention which will include tailored parent/patient education, appointment scheduling assistance, and primary care team trainings.

Interventions

Intervention Arm

Within the intervention clinics, parents of patients between the ages of 10-12 (who are eligible for the HPV vaccine) will receive a culturally tailored customized HPV vaccine message and testimonial video from a patient/survivor of an HPV associated cancer (e.g., oropharyngeal, or cervical) via the MyChart patient portal. Parents will also receive a personal call from the research coordinator to remind them that their child is due for the HPV vaccine. If the parent is interested in scheduling the HPV vaccine appointment during this call, the research coordinator will transfer the parent to UC Davis appointment call center to schedule the appointment. Also, primary care team members will receive a semi-annual learn at lunch workshop focused on strategies to introduce the HPV vaccine to parents and how to address concerns from vaccine hesitant parents. Workshop content will be tailored/adapted to include patient/parent cultural considerations.

Primary outcome measure

  • Primary Outcome: Evaluation [ Time Frame: One year ]

Central Contacts and Locations

Central contacts

Locations

University of California Davis Health

Recruiting

Sacramento, California, United States, 95817

Contacts

Julie HT Dang, PhD

jtdang@ucdavis.edu

More Information

Sponsor

University of California, Davis

Last update posted

Aug 11, 2026

Last verified

Aug, 2026

Keywords

  • HPV
  • Human Papillomavirus

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of California, Davis on 2026-08-11.